{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:14:50Z","timestamp":1792790090864,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Maisonneuve-Rosemont Hospital Nephrology Division"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kidney failure is associated with a high burden of morbidity and mortality. Previous studies have raised the possibility that arteriovenous fistula (AVF) creation may attenuate eGFR decline. This study aimed to compare eGFR decline in predialysis patients with an AVF, matched to patients oriented toward peritoneal dialysis (PD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Predialysis patients with an AVF and those oriented toward PD were retrospectively matched using a propensity score. Time zero was defined as the \u201cAVF creation date\u201d for the AVF group and the \u201cdate when eGFR was closest to the matched patient\u2019s eGFR at AVF creation\u201d for the PD group. Crude and predicted eGFR decline in AVF and PD groups were compared before and after time zero using mixed-effect linear regressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 61 pairs were matched. Crude annual eGFR decline before AVF creation\/time zero was \u22124.1 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year in the AVF group versus \u22125.3 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year in the PD group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.75) and after time zero, \u22122.5 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year in the AVF group versus \u22124.5 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year in the PD group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.02). The predicted annual decline decreased from \u22125.1 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year in the AVF group before AVF creation to \u22122.8 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year after (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01), whereas there was no difference in the PD group (\u22125.5 versus \u22125.1 ml\/min per m\n                      <jats:sup>2<\/jats:sup>\n                      per year respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.41).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this matched study, AVF creation was associated with a deceleration of kidney function decline compared with a control PD-oriented group. Prospective studies are needed to assess the potential mechanisms between vascular access creation and eGFR slope attenuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0005072020","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T22:03:08Z","timestamp":1605823388000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study"],"prefix":"10.34067","volume":"2","author":[{"given":"Marie-\u00c8ve","family":"Dupuis","sequence":"first","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Philippe","family":"Laurin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Goupil","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Sacr\u00e9-C\u0153ur de Montreal Hospital and Research Center, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"B\u00e9nard","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Pichette","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lafrance","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Department of Pharmacology and Physiology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Elftouh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pichette","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Division of Nephrology, Sacr\u00e9-C\u0153ur de Montreal Hospital and Research Center, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-1404","authenticated-orcid":false,"given":"Annie-Claire","family":"Nadeau-Fredette","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"},{"name":"Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"issue":"Suppl 1","key":"B1-20250825","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US Renal Data System 2016 annual data report: Epidemiology of kidney disease in the United States [published correction appears in Am J Kidney Dis 69: 712, 2017 10.1053\/j.ajkd.2017.03.001]","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.ajkd.2005.02.031","article-title":"Hemodialysis complications","volume":"45","author":"Himmelfarb","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B3-20250825","first-page":"9","article-title":"Prevalence of depressive symptoms among hemodialysis and peritoneal dialysis patients","volume":"9","author":"AlDukhayel","year":"2015","journal-title":"Int J Health Sci (Qassim)"},{"issue":"Suppl 6","key":"B4-20250825","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ndt\/14.suppl_6.31","article-title":"Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: Costs and reimbursement\/funding of ESRD therapies","volume":"14","author":"De Vecchi","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.ajkd.2008.06.023","article-title":"Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort","volume":"52","author":"Levin","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1681\/ASN.2007040422","article-title":"Age affects outcomes in chronic kidney disease","volume":"18","author":"O\u2019Hare","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"B8-20250825","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI Clinical Practice Guideline for Vascular Access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/ndt\/gfv082","article-title":"Arteriovenous fistula creation may slow estimated glomerular filtration rate trajectory","volume":"30","author":"Golper","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B10-20250825","first-page":"1330","article-title":"Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease","volume":"32","author":"Sumida","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12882-019-1607-4","article-title":"Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients","volume":"20","author":"B\u00e9nard","year":"2019","journal-title":"BMC Nephrol"},{"key":"B12-20250825","article-title":"Arteriovenous access placement and renal function decline [published online ahead of print October 30, 2019]","author":"Hahn Lundstr\u00f6m","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med 155: 408, 2011]","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B14-20250825","first-page":"196","article-title":"The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline","volume":"32","author":"Weekers","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000006980","article-title":"Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft","volume":"92","author":"De Lima","year":"1999","journal-title":"Cardiology"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"348","DOI":"10.20452\/pamw.1349","article-title":"To close or not to close: Fistula ligation and cardiac function in kidney allograft recipients","volume":"122","author":"G\u0142owi\u0144ski","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ndt\/16.2.368","article-title":"Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients","volume":"16","author":"van Duijnhoven","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/ndt\/gfv281","article-title":"Arteriovenous fistula as a nephroprotective intervention in advanced CKD: Scientific discovery and explanation, and the evaluation of interventions","volume":"30","author":"Locatelli","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial","volume":"375","author":"B\u00f8tker","year":"2010","journal-title":"Lancet"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1001\/jama.2015.4189","article-title":"Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: A randomized clinical trial","volume":"313","author":"Zarbock","year":"2015","journal-title":"JAMA"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2011.156","article-title":"Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery","volume":"80","author":"Zimmerman","year":"2011","journal-title":"Kidney Int"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote ischemic preconditioning and outcomes of cardiac surgery","volume":"373","author":"Hausenloy","year":"2015","journal-title":"N Engl J Med"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000353708","article-title":"Creation of an arteriovenous fistula is associated with significant acute local and systemic changes in microvascular function","volume":"123","author":"Korsheed","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"e011183","DOI":"10.1161\/JAHA.118.011183","article-title":"Effects of arteriovenous fistula on blood pressure in patients with end-stage renal disease: A systematic meta-analysis","volume":"8","author":"Scholz","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B26-20250825","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1093\/ndt\/gfp276","article-title":"The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease","volume":"24","author":"Utescu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/ndt\/gfq851","article-title":"Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function","volume":"26","author":"Korsheed","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1046\/j.1523-1755.1999.00433.x","article-title":"Effects of arteriovenous fistulas on cardiac oxygen supply and demand","volume":"55","author":"Bos","year":"1999","journal-title":"Kidney Int"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/ajkd.2002.35685","article-title":"The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy","volume":"40","author":"Ori","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ajh\/hpz136","article-title":"Determinants of increased central excess pressure in dialysis: Role of dialysis modality and arteriovenous fistula","volume":"33","author":"Pare","year":"2020","journal-title":"Am J Hypertens"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/ajkd.2001.26833","article-title":"Timing of nephrologist referral and arteriovenous access use: The CHOICE study","volume":"38","author":"Astor","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B32-20250825","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1046\/j.1523-1755.2001.00947.x","article-title":"Type of vascular access and mortality in U.S. hemodialysis patients","volume":"60","author":"Dhingra","year":"2001","journal-title":"Kidney Int"},{"key":"B33-20250825","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.ASN.0000109668.05157.05","article-title":"Vascular access and all-cause mortality: A propensity score analysis","volume":"15","author":"Polkinghorne","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B34-20250825","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0272-6386(13)80002-9","article-title":"Canadian hemodialysis morbidity study","volume":"19","author":"Churchill","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"B35-20250825","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1523-1755.1999.0550031081.x","article-title":"Septicemia in dialysis patients: Incidence, risk factors, and prognosis","volume":"55","author":"Powe","year":"1999","journal-title":"Kidney Int"},{"key":"B36-20250825","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1681\/ASN.V981507","article-title":"Subclavian vascular access stenosis in dialysis patients: Natural history and risk factors","volume":"9","author":"Hern\u00e1ndez","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B37-20250825","doi-asserted-by":"crossref","first-page":"c257","DOI":"10.1159\/000321867","article-title":"Right ventricular diastolic function in dialysis patients could be affected by vascular access","volume":"118","author":"Di Lullo","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"B38-20250825","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1542-4758.2010.00518.x","article-title":"High-output heart failure secondary to arteriovenous fistula","volume":"15","author":"Stern","year":"2011","journal-title":"Hemodial Int"},{"key":"B39-20250825","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/hr.2016.50","article-title":"Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease","volume":"39","author":"Wohlfahrt","year":"2016","journal-title":"Hypertens Res"},{"key":"B40-20250825","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1525-139X.2006.00186.x","article-title":"Pulmonary hypertension in hemodialysis patients: An unrecognized threat","volume":"19","author":"Yigla","year":"2006","journal-title":"Semin Dial"},{"key":"B41-20250825","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ndt\/gfv295","article-title":"Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period","volume":"31","author":"van de Luijtgaarden","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B42-20250825","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06840712","article-title":"The USRDS: What you need to know about what it can and can\u2019t tell us about ESRD","volume":"8","author":"Foley","year":"2013","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005072020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:01:50Z","timestamp":1786478510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005072020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0005072020","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}